Alan H. Bryce, MD @AlanBryce9 @MayoClinic #ASCO21 #Pros
Alan H. Bryce, MD, Medical Director of the Genomic Oncology Clinic at Mayo Clinic Arizona speaks about the ASCO 2021 Abstract – A phase 1b study of novel i
Alan H. Bryce, MD, Medical Director of the Genomic Oncology Clinic at Mayo Clinic Arizona speaks about the ASCO 2021 Abstract – A phase 1b study of novel i
Introduction During a comprehensive presentation by Dr. Catherine Coombs at UC Irvine, insights into the unique challenges and opportunities of using CAR T-c
Introduction At a recent conference, Dr. Anjali Advani of the Cleveland Clinic discussed the transformative role of Chimeric Antigen Receptor T-cell (CAR-T)
Introduction During the CAR-T & Bispecifics Conference, Dr. Brian Sworder, MD, from UCI Irvine, shared compelling insights on the utility of circulating
Introduction During the recent CAR-T & Bispecifics conference, Dr. Nitin Jain, MD, from MD Anderson Cancer Center in Houston, Texas, presented a challeng
Introduction The recent findings from the DESTINY-Breast06 Phase III trial signify a potential shift in the treatment landscape for HR-positive, HER2-low met
Introduction The US Food and Drug Administration (FDA) recently approved nogapendekin alfa inbakicept-pmln (Anktiva), used in conjunction with bacillus Calme
Dive into the SYNC-T technology by Syncromune® Inc. and its groundbreaking approach to hormone-refractory prostate cancer. Learn how it stimulates an immune response within the…
Introduction to Emerging Therapies in ALL Management … Dr. Elias Jabbour shared recent developments in the treatment of acute lymphoblastic leukemia (ALL) during a recent…
Dr. Scott Kopetz discussed the KRYSTAL-1 study at AACR, presenting promising results of combining adagrasib and cetuximab to target KRASG12C mutated colorectal cancer, reporting a…
Dr. Ajay Goel presented a novel blood-based liquid biopsy for early detection of pancreatic cancer, utilizing a combination of microRNAs and exosomes to achieve a…